ArticleOncoimmunology

Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma.

Kenzo Ohara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.